Objective To compare the curative effect of sublingual immunotherapy (SLIT) with standardized dermatophagoides farina drops in monosensitized and polysensitized children with allergic. Methods A total of 150 pediatric allergic rhinitis patients were enrolled as desensitization group and were allocated into monosensitized group (61 cases) and polysensitized group (89 cases) according to the number of coexisting allergens.Meanwhile 32 allergic rhinitis children treated by pharmacotherapy during the same period were collected as control group.The symptom scores (TNSS),drug scores (TMS) and visual analogue scale(VAS) were assessed at the beginning,6 months,1 year and 2 years of the treatment. Results The scores of TNSS and VAS in desensitization were slightly higher than those in the control after 6 months treatment,but without difference at 1 year and 2 years;The score of TMS had significant improvement in desensitization compared with the corresponding points in control.All the parameters in monosensitized group were equivalent with polysensitizend group,except the score of TMS was slightly lower than the polysensitizend group at 6 months. Conclusions Dust mites under the SLIT can significantly improve nasal symptoms of the monoallergen sensitized and polyallergen sensitized allergic children,reduce the symptomatic drug use,and two groups have similar curative effects.The rise of dust mites specific IgG4 can be used as immunotherapy effective predictors.
Key words
allergic rhinitis /
sublingual immunotherapy /
dust mites /
cross desensitization
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎特异性免疫治疗专家共识 [J].中华耳鼻咽喉头颈外科杂志,2011,46(12):976-980.
[2] Incorvaia C.Treating allergic rhinitis by sublingual immunotherapy:a review[J].Ann Ist Super Sanita,2012,48(2):172-176.
[3] Pitsios C,Demoly P,Bilo MB,et al.Clinical contraindications to allergen immunotherapy:an EAACI position paper[J].Allergy,2015,70(8):897-909.
[4] Rodriguez SO.Sublingual immunotherapy in allergic rhinitis and asthma in 2-5 year-old children sensitized to mites[J].Rev Alerg Mex,2008,55(2):71-75.
[5] Elenburg S,Blaiss MS.Current status of sublingual immunotherapy in the United States[J].World Allergy Organ J,2014,7(1):24-28.
[6] Eifan AO,Calderon MA,Durham SR.Allergen immunotherapy for house dust mite:clinical efficacy and immunological mechanisms in allergic rhinitis and asthma[J].Expert Opin Biol Ther,2013,13(11):1543-1556.
[7] Calderon MA,Cox L,Casale TB,et al.Multiple allergen and single-allergen immunotherapy strategies in polysensitized patiengs:looking at the published evidence[J].Allergy Clin Immunol,2012,129(4):929-934.
[8] Bahceciler NN,Galip N,Cobanogul N,et al.Multiallergen-specific immunotherapy in polysensitized patients:where are we? [J].Immunotherapy,2013,5(2):183-190.
[9] Ciprandi G,Alesina R,De Amici M.Serum specific IgE:biomarker for specific immunotherapy responsiveness?[J].Allergol Immunopathol,2014,42(4):369-3718.